NIFTY 50

Bharat Biotech's Covaxin shows 81% efficacy in Phase 3 trials

Updated : March 03, 2021 11:26 PM IST

The clinical trial will continue and final analysis will be done when 130 confirmed symptomatic Covid positive cases are accrued and hence the data may vary then.
Nearly 10 percent of the volunteers were over the age of 60 and 4,500 with co-morbidities.
Published : March 03, 2021 05:12 PM IST

You May Also Like

Live TV

recommended for you